Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Epilepsies of early childhood are frequently resistant to therapy and often associated with cognitive and behavioural comorbidity. Aetiology focused precision medicine, notably gene-based therapies, may prevent seizures and comorbidities. Epidemiological data utilizing modern diagnostic techniques including whole genome sequencing and neuroimaging can inform diagnostic strategies and therapeutic trials. We present a 3-year, multicentre prospective cohort study, involving all children under 3 years of age in Scotland presenting with epilepsies. We used two independent sources for case identification: clinical reporting and EEG record review. Capture-recapture methodology was then used to improve the accuracy of incidence estimates. Socio-demographic and clinical details were obtained at presentation, and 24 months later. Children were extensively investigated for aetiology. Whole genome sequencing was offered for all patients with drug-resistant epilepsy for whom no aetiology could yet be identified. Multivariate logistic regression modelling was used to determine associations between clinical features, aetiology, and outcome. Three hundred and ninety children were recruited over 3 years. The adjusted incidence of epilepsies presenting in the first 3 years of life was 239 per 100 000 live births [95% confidence interval (CI) 216–263]. There was a socio-economic gradient to incidence, with a significantly higher incidence in the most deprived quintile (301 per 100 000 live births, 95% CI 251–357) compared with the least deprived quintile (182 per 100 000 live births, 95% CI 139–233), χ2 odds ratio = 1.7 (95% CI 1.3–2.2). The relationship between deprivation and incidence was only observed in the group without identified aetiology, suggesting that populations living in higher deprivation areas have greater multifactorial risk for epilepsy. Aetiology was determined in 54% of children, and epilepsy syndrome was classified in 54%. Thirty-one per cent had an identified genetic cause for their epilepsy. We present novel data on the aetiological spectrum of the most commonly presenting epilepsies of early childhood. Twenty-four months after presentation, 36% of children had drug-resistant epilepsy (DRE), and 49% had global developmental delay (GDD). Identification of an aetiology was the strongest determinant of both DRE and GDD. Aetiology was determined in 82% of those with DRE, and 75% of those with GDD. In young children with epilepsy, genetic testing should be prioritized as it has the highest yield of any investigation and is most likely to inform precision therapy and prognosis. Epilepsies in early childhood are 30% more common than previously reported. Epilepsies of undetermined aetiology present more frequently in deprived communities. This likely reflects increased multifactorial risk within these populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common DEE syndrome is Infantile Epileptic Spasms Syndrome (IESS) with an incidence of 30.7 in 100,000 individuals (95% CI 22.9-40.2) to 48.9 in 100,000 individuals (95% CI 37.0-64.7);~27% of IESS have a structural aetiology 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Incidence estimates have been reported for many DEE syndromes; however, around one-third of patients cannot be classified as having a specific syndrome 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In comparison, the estimated incidence of all epilepsies presenting under 3 years was 239 in 100,000 (95% CI 216-263) in a prospective study in Scotland, UK, with DEEs accounting for 86.1 in 100,000 (95% CI 72.7-101.3)children 9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Self-citationKwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073 · cited 1×
“On a population level, the highest age-specific incidences of 460 per 100 000 are observed in children under 5 years of age and in adults over 65 years of age.(9) A significant proportion (35%) of children presenting with epilepsies in the first 3 years of life develop drugresistant seizures.”
BackgroundTrial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711 · cited 1×
“Precise clinical classification of epilepsy syndrome, and identification of a genetic aetiology, helps guide therapeutic strategy, exemplified by randomized controlled trials in Lennox-Gastaut syndrome,(4,5) and Dravet syndrome.(6,7) For the individually rare but severe epilepsies caused by large effect mutations in a…”
BackgroundEffect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015
Self-citationThiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Self-citationState of the Art Review: Poverty and the Developing Brain
Johnson, S. B., Riis, J. L., & Noble, K. G. (2016) · Pediatrics · doi:10.1542/peds.2015-3075 · Cited by 624
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationPerucca, E., Perucca, P., White, H. S., & Wirrell, E. C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00151-5 · Cited by 305
International consensus on diagnosis and management of Dravet syndrome
Wirrell, E. C., Hood, V., Knupp, K. G., Meskis, M. A., Nabbout, R., Scheffer, I. E., Wilmshurst, J., & Sullivan, J. (2022) · Epilepsia · doi:10.1111/epi.17274 · Cited by 249
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationDonnan, A. M., Schneider, A. L., Russ-Hall, S., Churilov, L., & Scheffer, I. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207080 · Cited by 97
Poke, G., Stanley, J., Scheffer, I. E., & Sadleir, L. G. (2023) · Neurology · doi:10.1212/wnl.0000000000206758 · Cited by 96
Sullivan, J. E., Benitez, A., Roth, J., Andrews, J. S., Shah, D., Butcher, E., Jones, A., & Cross, J. H. (2024) · Epilepsia · doi:10.1111/epi.17866 · Cited by 86
“…to affect fewer than seven per 100 000 individuals across all 10 articles, with ranges of 2.17–6.5 per 100 000 individuals for incidence proportion estimates (eight articles) 18,26,28,30,40,54–56 and 1.2–6.5 per 100 000 individuals for prevalence estimates (four articles) 30,39,41,55 (Table 1).”
InfluentialScheffer, I. E., French, J. A., Valente, K. D. R., Auvin, S., Cross, J. H., & Specchio, N. (2025) · Epilepsia · doi:10.1111/epi.18265 · Cited by 72
Improving epilepsy diagnosis across the lifespan: approaches and innovations
Pellinen, J., Foster, E., Wilmshurst, J. M., Zuberi, S. M., & French, J. A. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00079-6 · Cited by 66
Self-citationData-driven historical characterization of epilepsy-associated genes
Macnee, M., Pérez‐Palma, E., López-Rivera, J. A., Ivaniuk, A., May, P., Møller, R. S., & Lal, D. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.12.005 · Cited by 46
Yozawitz, E. G. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2300188 · Cited by 44
Oral Health Care for Children and Youth With Developmental Disabilities: Clinical Report
Sarvas, E. W., Webb, J., Landrigan-Ossar, M. F., Yin, L., HEALTH, S. O. O., Karp, J. M., Beyer, E. L., Brooks, C., Feldman, L. M., Kimball, C. E., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2024-067603 · Cited by 43
Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine
Snyder, H., Jain, P., RamachandranNair, R., Jones, K., & Whitney, R. (2024) · Genes · doi:10.3390/genes15030266 · Cited by 42
“IESS has an estimated incidence of 30 per 100,000 live births, and previous studies suggest a slightly higher incidence in males compared to females [4,5].”
ResultVikin, T., Lossius, M. I., Brandlistuen, R. E., Chin, R., & Aaberg, K. M. (2025) · Epilepsia · doi:10.1111/epi.18238 · Cited by 37
“6,16,17 This gap in the knowledge about the onset and progression of childhood and youth epilepsies, particularly regarding advancements in diagnostics and updated classifications, needs to be addressed.”
Busch, R. M., Dalton, J. E., Jehi, L. E., Ferguson, L., Krieger, N. I., Struck, A. F., & Hermann, B. P. (2023) · Neurology · doi:10.1212/wnl.0000000000207266 · Cited by 36
Predicting functional effects of ion channel variants using new phenotypic machine learning methods
Boßelmann, C. M., Hedrich, U. B. S., Lerche, H., & Pfeifer, N. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010959 · Cited by 34
“The majority of these variants are associated with Dravet syndrome, a severe developmental and epileptic encephalopathy (DEE) and the most common drug-resistant genetic epilepsy [3].”
Pilčević, D., Djuric-Jovicic, M. D., Antonijević, M., Bačanin, N., Jovanović, L., Zivkovic, M. Z., Dragović, M., & Bisevac, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1267011 · Cited by 34
Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice
Scheffer, I. E., Bennett, C. A., Gill, D., de Silva, M. G., Boggs, K., Marum, J., Baker, N., Flagship, A. G. D., Palmer, E. E., & Howell, K. B. (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15308 · Cited by 31
Epilepsy syndromes: the 2022 ILAE definition and classification
Blinov, D. V. (2022) · Epilepsy and Paroxysmal Conditions · doi:10.17749/2077-8333/epi.par.con.2022.123 · Cited by 34
Dravet syndrome in children—A population-based study
Bjurulf, B., Reilly, C. J., Sigurdsson, G. V., Thunström, S., Kolbjer, S., & Hallböök, T. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106922 · Cited by 31
“It must be noted that in a recent study from Scotland all 11 children who met criteria for DS had an SCN1A variant (Symonds et al., 2021).”
Fan, H., Yang, M., Lin, L., Chiang, K.-L., & Chen, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010031 · Cited by 31
“Data indicate that DS has a global incidence of approximately 6.5 per 100,000 live births [9,17–19].”
BackgroundInfluentialBush, K. J., Cullen, E. M., Mills, S., Chin, R., Thomas, R. H., Kingston, A., Pickrell, W. O., & Ramsay, S. E. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00132-4 · Cited by 28
Drug-resistant epilepsy at the age extremes: Disentangling the underlying etiology
Bartolini, E., Ferrari, A. R., Lattanzi, S., Pradella, S., & Zaccara, G. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108739 · Cited by 26
Long-term predictors of developmental outcome and disease burden in SCN1A-positive Dravet syndrome
Feng, T., Makiello, P., Dunwoody, B., Steckler, F., Symonds, J. D., Zuberi, S. M., Dorris, L., & Brunklaus, A. (2023) · Brain Communications · doi:10.1093/braincomms/fcae004 · Cited by 25
Self-citationMahawar, S., Rakshit, D., Patel, I., Gore, S. K., Sen, S., Ranjan, O. P., & Mishra, A. (2024) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2024.102752 · Cited by 24
A systematic review of psychosocial interventions for children and young people with epilepsy
Mercier, A., & Dorris, L. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.02.002 · Cited by 23
Self-citationStatus epilepticus and early development: Neuronal injury, neurodegeneration, and their consequences
Thompson, K. W. (2022) · Epilepsia Open · doi:10.1002/epi4.12601 · Cited by 22
Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?
Ng, A. C., Choudhary, A., Barrett, K. T., Gavrilovici, C., & Scantlebury, M. H. (2023) · Epilepsia · doi:10.1111/epi.17841 · Cited by 22
A registry for Dravet syndrome: The Italian experience
Balestrini, S., Doccini, V., Giometto, S., Lucenteforte, E., De Masi, S., Giarola, E., Brambilla, I., Pieroni, F., Perulli, M., Battaglia, D., et al. (2023) · Epilepsia Open · doi:10.1002/epi4.12730 · Cited by 21
Agarwala, P., Narang, B., Geetha, T. S., Kurwale, N. S., Samson, P. L., Golani, T., Mahadevia, U., Ramprasad, V. L., Murugan, S., Chatterjee, S., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad243 · Cited by 21
“15,24 In fact, all our EIDEE-metabolic patients had VR epilepsy, a potentially treatable cause of EIDEE with good long-term neurodevelopmental and epilepsy outcome.”
BackgroundLee, J., Kim, Y. O., Lim, B. C., & Lee, J. (2023) · Epilepsia Open · doi:10.1002/epi4.12708 · Cited by 20
Jansson, J. S., Bjurulf, B., Dellenmark‐Blom, M., Hallböök, T., & Reilly, C. J. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109790 · Cited by 20
Henry, O. J., Ygberg, S. E., Barbaro, M., Lesko, N., Karlsson, L., Peña‐Pérez, L., Båvner, A., Töhönen, V., Lindstrand, A., Stödberg, T., et al. (2025) · Epilepsia · doi:10.1111/epi.18403 · Cited by 19
Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy
Kim, S. H., Seo, J., Kwon, S. S., Teng, L., Won, D., Shin, S., Lee, J. S., Lee, S., Choi, J. R., & Kang, H. (2023) · Epilepsia · doi:10.1111/epi.17857 · Cited by 19
“3,45,47 Here, we could compare diagnostic yields across the different epilepsy syndromes and subgroups using the same laboratory methods.”
MethodEpilepsy surgery in developmental and epileptic encephalopathies
Ramantani, G., & Wirrell, E. C. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109985 · Cited by 18
Medyanik, A. D., Anisimova, P. E., Kustova, A. O., Tarabykin, V. S., & Kondakova, E. V. (2025) · Biomolecules · doi:10.3390/biom15010133 · Cited by 18
“About 40% of epileptic seizures in the first years of life are caused by developmental and epileptic encephalopathy (DEE) [1,2].”
Carroll, J. H., Cross, J. H., Hickson, M., Williams, E., Aldridge, V., & Collinson, A. (2023) · Epilepsia · doi:10.1111/epi.17513 · Cited by 18
Kolosky, T., Goldstein Shipper, A., Sun, K., Tozduman, B., Bentzen, S., Moosa, A. N., & Erdemir, G. (2024) · Epilepsia Open · doi:10.1002/epi4.13007 · Cited by 17
Alterations of Plasma Pro-Inflammatory Cytokine Levels in Children with Refractory Epilepsies
Gakharia, T., Bakhtadze, S., Lim, M. J., Khachapuridze, N., & Kapanadze, N. (2022) · Children · doi:10.3390/children9101506 · Cited by 17
Hollenshead, P. P., Jackson, C. N., Cross, J., Witten, T., Anwar, A. I., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07078-z · Cited by 17
“Following the largest study of IESS to date, the ICSS investigators concluded that early and effective treatment had positive correlation with improved prognosis of developmental outcomes and decreased progression to other epilepsy types particularly Lennox–Gestalt syndrome [11, 12].”
InfluentialZhao, J., Li, S., Zhang, N., Cui, C., Wang, T., Fan, M., Zeng, J., & Xie, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1459392 · Cited by 16
Use of Stiripentol in Dravet Syndrome: A Guide for Clinicians
Wheless, J. W., & Weatherspoon, S. E. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.10.015 · Cited by 16
Zhang, L., Xu, R., Huang, H., Yang, J., Yu, C., Zhang, H., & Xu, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1650909 · Cited by 15
Kapoor, D., Garg, D., Beriwal, N., Sidharth, Kumar, A., Mukherjee, S. B., Pemde, H. K., & Sharma, S. (2023) · Journal of Child Neurology · doi:10.1177/08830738231174493 · Cited by 14
Symonds, J. D., Park, K., Mignot, C., Macleod, S., Armstrong, M., Ashrafian, H., Bernard, G., Brown, K. E., Brunklaus, A., Callaghan, M., et al. (2024) · Epilepsia · doi:10.1111/epi.18115 · Cited by 14
“1,34,35,36,37 The number of genes associated with DEEs in which generalized seizures are the predominant seizure type are relatively few, the most established being SLC2A1 , 2 SYNGAP , 38 CHD2 , 39 and SLC6A1 .”
Self-citationAlamad, B., Elliott, K., & Knight, J. C. (2024) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25 · Cited by 13
“The use of genomic sequencing for diagnosis and direct management has been used in many diseases including musculoskeletal, neurological, metabolic and complex syndromes affecting multiple tissues and processes (Ko et al., 2018; Symonds et al., 2021).”
Self-citationLacey, A., Jones, C., Ryoo, S. G., Stephen, J., Weir, C. J., Pickrell, W. O., & Chin, R. (2024) · Seizure · doi:10.1016/j.seizure.2024.09.008 · Cited by 13
“Although there is an association between epilepsy and deprivation there is little evidence that this relationship holds true in SeLECTS [10,11].”
BackgroundNeurologic orphan diseases: Emerging innovations and role for genetic treatments
Kioutchoukova, I. P., Foster, D. T., Thakkar, R. N., Foreman, M. A., Burgess, B. J., Toms, R., Valero, E., & Lucke-Wold, B. P. (2023) · World Journal of Experimental Medicine · doi:10.5493/wjem.v13.i4.59 · Cited by 13
Mei, D., Balestrini, S., Parrini, E., Gambardella, A., Annesi, G., GIORGIS, V. D., Gana, S., Bassi, M. T., Zucca, C., Elia, M., et al. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110328 · Cited by 13
“14 15 Our survey provides an imperfect but reliable quantitative estimate on the set of rare diseases grouped under the definition of DEEs.”
Genome Sequencing After Exome Sequencing in Pediatric Epilepsy
D’Gama, A. M., Shao, W., Smith, L. A., Koh, H. Y., Davis, M., Koh, J., Oby, B. T., Urzua, C. I., Sheidley, B. R., Rockowitz, S., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3582 · Cited by 12
Agathe, J. D. S., Monin, P., Riccardi, F., Nava, C., Arnaud, L., Mignot, C., Ville, D. M., Auvin, S., Tardieu, S., Larcher, K., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70324 · Cited by 12
“This contrasted with the findings of [26], who reported 42% of genetic diagnostics ( n = 52).”
Ruan, Y., Deng, X., Liu, J., Xiao, X., & Yang, Z. H. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1199780 · Cited by 13
Epilepsy Genetics: Advancements in the Field and Impact on Clinical Practice
Hunter, S. E., Jalazo, E., Felton, T., Heinzen, E. L., & Shiloh‐Malawsky, Y. (2022) · Epilepsy · doi:10.36255/exon-publications-epilepsy-genetics · Cited by 12
Chu, D. Y., Adluru, N., Nair, V. A., Choi, T., Adluru, A., Garcia‐Ramos, C., Dabbs, K., Mathis, J. R., Nencka, A. S., Gundlach, C., et al. (2023) · Epilepsia · doi:10.1111/epi.17702 · Cited by 11
Epilepsy diagnosis and treatment in children – new hopes and challenges – literature review
Urbańska, S., Leśniewski, M., Welian-Polus, I., Witas, A., Szukała, K., & Chrościńska–Krawczyk, M. (2024) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/185469 · Cited by 11
Lee, J., Choi, A., Kim, S., & Yoo, I. H. (2024) · Neurology International · doi:10.3390/neurolint16040066 · Cited by 11
“Additionally, precision medicine approaches tailored to individual patients through genetic diagnostics may have reduced treatment failure [32].”
BackgroundBalestrini, S., & Scheffer, I. E. (2026) · CNS Drugs · doi:10.1007/s40263-026-01276-x · Cited by 11
“DS presents by 19 months of age [2], with an incidence of 1 per 15,500 [5] or 6.5 per 100,000 live births [6].”
InfluentialPanthi, S., Chapman, P. A., Szyszka, P., & Beck, C. W. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15836 · Cited by 11
“Children under 5 years of age have the highest age-specific incidences ( ~ 60 per 100 000) (Symonds et al., 2021 ).”
Feygina, A. A., Koshelyaevskaya, Y., Dibué, M., Voronkova, K. V., Klochkov, M. N., Koroleva, N. Y., Ivanov, S. S., Bolshakova, E. S., & Fatykhova, E. F. (2023) · Brain and Behavior · doi:10.1002/brb3.3076 · Cited by 11
“…appears to be higher than that in studies of VNS in aDRE population that included children and adults (Elliott et al., 2011), but it is aligned with the findings from Symonds and colleagues who identified genetic etiologies in 31% of pediatric patients under 3 years of age (Symonds et al., 2021).”
ResultEffectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
Yang, C., Liu, Z., Peng, Y., Zhang, L., & Yu, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1186768 · Cited by 11
Stenshorne, I., Syvertsen, M. R., Ramm‐Pettersen, A., Henning, S., Weatherup, E., Bjørnstad, A., Brüggemann, N., Spetalen, T., Selmer, K. K., & Koht, J. A. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.965282 · Cited by 11
Vicente, A. G., Dieguez, A. C., Amarante, B. T., Hortolam, I. M., Carneiro, S. M. B., & Ruela, G. D. A. (2024) · Research Society and Development · doi:10.33448/rsd-v13i3.45203 · Cited by 10
Innes, E. A., Han, V. X., Patel, S., Farrar, M. A., Gill, D. S., Mohammad, S. S., & Dale, R. C. (2025) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16273 · Cited by 10
“22,27 The GO pathways identified in IESS in our review and previous studies encompassed themes of brain development, epigenetic control of cellular processes, and neurotransmission.”
Gui, J., Wang, L., Meng, L., Zhang, X., Ma, J., & Jiang, L. (2025) · Acta Epileptologica · doi:10.1186/s42494-025-00223-5 · Cited by 10
“Epilepsy has a high incidence in early childhood [5].”
Jonsson, H., Gaily, E. K., Stjerna, S., Joensuu, T. H., Johari, M., Lehesjoki, A., & Linnankivi, T. (2024) · Epilepsia Open · doi:10.1002/epi4.12966 · Cited by 10
“2,34 Fifth, uniform genetic testing of all infants would have increased the reliability of our results and probably diminished the group of unknown etiology.”
BackgroundResultInfluentialEpidemiology and outcome of infantile spasms in Denmark in 1996–2019
Winther, C. C. H., Klein‐Petersen, A. W., Préel, M., Kofoed, I. R., Nissen, I. B., Axelgaard, S., Green, J. B., Miranda, M. J., & Hoei‐Hansen, C. E. (2024) · Seizure · doi:10.1016/j.seizure.2024.07.008 · Cited by 10
“The study included all children who had an EEG in the years 2015 to 2017 [24].”
Genetic aetiologies in relation to response to the ketogenic diet in 226 children with epilepsy
Dahlin, M. G., Stödberg, T., Ekman, E., Töhönen, V., & Wedell, A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf134 · Cited by 10
Population‐based study of rare epilepsy incidence in a US urban population
Barbour, K. K., Tian, N., Yozawitz, E. G., Wolf, S. M., McGoldrick, P. E., Sands, T. T., Nelson, A. L. A., Basma, N., & Grinspan, Z. M. (2024) · Epilepsia · doi:10.1111/epi.18029 · Cited by 9
“38 As genetic testing becomes more widely used clinically, there are opportunities for future research to update epidemiologic estimates using EHR data.”
Morris, G., Avoli, M., Bernard, C., Connor, K., de Curtis, M., Dulla, C. G., Jefferys, J. G. R., Psarropoulou, C., Staley, K. J., & Cunningham, M. O. (2023) · Epilepsia · doi:10.1111/epi.17744 · Cited by 9
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?
Wirrell, E. C., Riney, K., Specchio, N., & Zuberi, S. M. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2254937 · Cited by 9
“Syndromes are more commonly recognized in early life and are identified in over half of children who have epilepsy onset before 3 years of age [22].”
BackgroundSelf-citationAdult phenotypes of genetic developmental and epileptic encephalopathies
Vakrinou, A., Pagni, S., Mills, J. D., Clayton, L. M. S., Balestrini, S., & Sisodiya, S. M. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf028 · Cited by 9
Riza, A., Streață, I., Roza, E., Budișteanu, M., Iliescu, C., Burloiu, C., Dobrescu, M. A., Dorobantu, S., Dragos, A., Grigorescu, A., et al. (2022) · Genes · doi:10.3390/genes13071253 · Cited by 9
“To appropriately address the polymorphic etiology of the disease [8], the diagnosis must rely on the use of the latest gene testing, neuroimaging, metabolic, and immunological techniques to raise the successful diagnosis rate [9] from that which can be achieved by precise electro-clinical phenotyping alone [1,10].”
MethodUhl, S., Konnyu, K. J., Wilson, R. F., Adam, G., Robinson, K. A., & Viswanathan, M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066872 · Cited by 9
Peer health advisor program to reduce the health risks of university students.
Carey, M. I. (1984) · Europe PMC (PubMed Central) · Cited by 9
Abath, C. B., Katyayan, A., Harini, C., Hussain, S. A., Bhalla, S., Singh, A., Donatelli, S., Karamian, A. G. S., Samanta, D., Sirsi, D., et al. (2025) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2025.10.005 · Cited by 8
Brain imaging traits and epilepsy: Unraveling causal links via mendelian randomization
Li, F., Tang, M., Hao, C., Yang, M., Pan, Y., & Lei, P. (2024) · Brain and Behavior · doi:10.1002/brb3.70051 · Cited by 8
Cognitive and brain health in juvenile myoclonic epilepsy: Role of social determinants of health
Struck, A. F., Garcia‐Ramos, C., Prabhakaran, V., Nair, V. A., Adluru, N., Adluru, A., Almane, D. N., Jones, J. E., & Hermann, B. P. (2025) · Epilepsia · doi:10.1111/epi.18296 · Cited by 8
Epilepsy syndromes classification
Wirrell, E. C., Specchio, N., Nabbout, R., Pearl, P. L., & Riney, K. (2025) · Epilepsia Open · doi:10.1002/epi4.70026 · Cited by 8
“16,17 18–20 Syndrome identification appears less common in adults with new-onset epilepsy, although data are lacking.”
Management of Developmental and Epileptic Encephalopathies
Vasquez, A., & Fine, A. L. (2025) · Seminars in Neurology · doi:10.1055/a-2534-3267 · Cited by 7
Nascimento, F. A., Hood, V. L., Yap, S. V., Sheikh, I., Meskis, M. A., & Thiele, E. A. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109368 · Cited by 7
Vertiginous epilepsy in the pediatric population
Wood, A. M., Thompson‐Harvey, A., & Kesser, B. W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1403536 · Cited by 7
Hassan, M. A., Awad, A. A., Marey, A., Amin, A. M., Elshahat, A., El-Moslemani, M., Mansour, A., Ramadan, S., & Aldemerdash, M. A. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08185-9 · Cited by 7
“In addition to the high incidence of epilepsy in early childhood, more than a third of affected children under the age of three develop drug-resistant epilepsy [3].”
Innes, E. A., Marne, F. A. L., Macintosh, R., Nevin, S. M., Briggs, N., Vivekanandarajah, S., Webster, R., Sachdev, R., & Bye, A. M. E. (2023) · Seizure · doi:10.1016/j.seizure.2023.12.013 · Cited by 7
Badura‐Stronka, M., Wołyńska, K., Winczewska‐Wiktor, A., Marcinkowska, J., Karolewska, D., Tomkowiak-Kędzia, D., Piechota, M., Przyborska, M., Kochalska, N., & Steinborn, B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1316933 · Cited by 7
American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
Freedman, D., Babatunde, I., Morgan, R. L., Abu‐Sawwa, R., Albert, D. V. F., Behbahani, M., Chapman, K. E., Fecske, E., Gaillard, W. D., Jones, M., et al. (2026) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597261433266 · Cited by 6
The Value of Long-term Video EEG Monitoring to Diagnose and Track Childhood Epilepsy.
Mohammadi, M., Badv, R. S., Rezaei, Z., Ashrafi, M., & Naeemi, F. (2024) · Iranian journal of child neurology. · doi:10.22037/ijcn.v18i1.43012 · Cited by 6
Özcan, M., Kanmaz, S., Şimşek, E., Toprak, D. E., Ölçülü, C. B., İnce, T., Yılmaz, Ö., Ataş, Y., Şen, G., Aykut, A., et al. (2025) · Epileptic Disorders · doi:10.1002/epd2.70012 · Cited by 6
Dressler, A., Bonfanti, L., Trimmel‐Schwahofer, P., Porsche, B., Bertoli, S., & Male, C. (2025) · Nutrients · doi:10.3390/nu17132085 · Cited by 6
“Infantile epileptic spasm syndrome (IESS) occurs in approximately 22 out of 100,000 live-born infants [1], accounting for approximately 10% of all epilepsies in the first years of life [2,3].”
The efficacy and safety of the ketogenic diet in infantile epileptic spasm syndrome: a meta-analysis
Zuo, C., Xu, K., Ni, K., Xiang, Y., Wang, Y., Liu, Z., & Sun, D. (2025) · Seizure · doi:10.1016/j.seizure.2025.08.029 · Cited by 7
Gut-brain cholinergic signaling mediates the antiseizure effects of Bacteroides fragilis
Jia, Y., Chen, H., Zou, Q., Chen, S., Li, J., Chen, Y., Lu, L., Hong, F., Jia, S., Jing, X., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.11.029 · Cited by 6
Long-Term Outcome of Neonatal Seizure with PACS2 Mutation: Case Series and Literature Review
Chou, I., Hou, J.-Y., Fan, W., Tsai, M., & Lin, K. (2023) · Children · doi:10.3390/children10040621 · Cited by 6
“The incidence of seizures in neonates and infants is estimated to be 7/100,000 live births [2,3].”
BackgroundWONOEP appraisal: Genetic insights into early onset epilepsies
Quatraccioni, A., Cases‐Cunillera, S., Balagura, G., Coleman, M., Rossini, L., Mills, J. D., Casillas-Espinosa, P. M., Moshé, S. L., Sankar, R., Baulac, S., et al. (2024) · Epilepsia · doi:10.1111/epi.18124 · Cited by 6
Lin, K.-N., Han, F., Wang, Y., Zhao, W., Wang, J., Li, Z., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599641 · Cited by 6
Endovascular embolization for medically refractory pediatric epilepsy: a case series
Xu, R., Srinivasan, E. S., Hung, A. L., Lee, R. P., Hughes, L. P., Johnson, E., Liu, C. J., Sun, L. R., Felling, R. J., Comi, A. M., et al. (2025) · Journal of NeuroInterventional Surgery · doi:10.1136/jnis-2025-023265 · Cited by 6
Yıldırım, M., Altıntaş, M., Uysal, E., Bektaş, Ö., & Teber, S. (2024) · Seizure · doi:10.1016/j.seizure.2024.03.005 · Cited by 5
Mao, D., Li, S., Xu, Y., Chen, H., Liu, P., & Hu, W.-G. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110055 · Cited by 5
“IESS is a rare condition, with an estimated incidence rate of 30.7 per 100,000 live births, primarily affecting children under 2 years old, with a peak onset age between 3 and 12 months [1,2].”
BackgroundInfluentialHealth Disparities and Inequities in Epilepsy
Correa, D. J., & Gutierrez, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-62727-9_5 · Cited by 5
Endocannabinoid signaling in epilepsy
Zeng, C., & Chen, C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107074 · Cited by 5
Wirrell, E. C. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109950 · Cited by 5
Zheng, L., Lin, L., & Zeng, Q. (2024) · Noise and Health · doi:10.4103/nah.nah_75_24 · Cited by 5
“[13] Currently, EP activity (whether epileptic seizures or EDs) is well recognized to have a detrimental effect on the developing brain.”
Metadata
- Authors
- Symonds, J. D., Elliott, K. S., Shetty, J., Armstrong, M., Brunklaus, A., Cutcutache, I., Diver, L. A., Dorris, L., Gardiner, S., Jollands, A., Joss, S., Kirkpatrick, M., McLellan, A., MacLeod, S., O’Regan, M., Page, M., Pilley, E., Pilz, D. T., Stephen, E., Stewart, K., Ashrafian, H., Knight, J. C., & Zuberi, S. M.
- Affiliations
- Royal Hospital for Children (GB)
- Centre for Human Genetics (GB)
- UCB Pharma (Belgium) (BE)
- UCB Pharma (United Kingdom) (GB)
- Queen Elizabeth University Hospital (GB)
- NHS Tayside (GB)
- University of Dundee (GB)
- Royal Aberdeen Children's Hospital (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-01
- Volume
- 144
- Issue
- 9
- Pages
- 2879-2891
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC8557326
- OpenAlex
- W3168961767
- Cited by
- 269
- References
- 44
- Citations by year
- 2026: 66 · 2025: 72 · 2024: 64 · 2023: 49 · 2022: 17
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Dravet Syndrome UK
- Epilepsy Research UK
- Glasgow Children’s Hospital Charity
- UCB Pharma
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- early childhood epilepsy, epilepsy incidence, socioeconomic deprivation, epilepsy etiology, drug-resistant epilepsy, global developmental delay, epilepsy syndromes, genetic epilepsy, whole genome sequencing, mark-recapture, epilepsy classification, Scotland, children under 3 years, gene therapy, precision medicine, neuroimaging, prospective cohort
- MeSH terms
- Drug Resistant Epilepsy, Child, Preschool, Epilepsy, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Retrospective Studies, Scotland, Socioeconomic Factors, Cohort Studies, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.